Pfizer Inc Announces EMA acceptance for Trumenba (Meningococcal Group B Vaccine) marketing authorization application...
Pfizer Inc announced the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA)...
Novartis announces FortiHFy clinical programme of Entresto
Fortifying Heart Failure clinical evidence and patient quality of life (FortiHFy) is an umbrella...
AstraZeneca highlights continued progress of oncology pipeline at ASCO 2016
73 abstracts presented at ASCO with 19 related to Lynparza and new potential medicines targeting...
AbbVies Inc Leadership in Gastroenterology Showcased at Digestive Disease Week with New HUMIRA Long-Term,...
Data presentations further evaluate HUMIRA® (adalimumab) for the treatment of inflammatory bowel diseases including moderate...
Spark Therapeutics, Pfizer Inc announce data from initial subjects in hemophilia B trial
Subjects received one-time administration of a highly optimized gene therapy at initial low dose...
Bayer AG to Showcase Latest Oncology Research at ASCO 2016
Bayer announced that data from several studies across its oncology portfolio will be presented at...
Merck & Co Inc Final overall survival data from KEYNOTE-006 and KEYNOTE-001 in Advanced...
Final Overall Survival Data from KEYNOTE-006 To Be Presented at ASCO; KEYTRUDA, the First Anti-PD-1...
GlaxoSmithKline presents new data from Breo Ellipta SUMMIT study in patients with COPD at...
GlaxoSmithKline and Innoviva, Inc announced that GlaxoSmithKline plc (GSK) presented new data at the American...
GlaxoSmithKline presents positive data for Anoro Ellipta in COPD patients who remained symptomatic on...
GlaxoSmithKline and Innoviva Inc announced results from data presented at the American Thoracic Society (ATS)...
Merck and Pfizer to Present Avelumab Data in Seven Different Cancers at ASCO Annual...
14 avelumab abstracts at ASCO 2016 highlight significant progress being made by the collaboration...